Showing results (131-140 of 162) with videos related to
Sort By:
Pageof 17
Accident; Analysis and Prevention|July 18, 2018
Modelling public bus/minibus transport accident severity in GhanaEnoch F Sam, Stijn Daniels, Kris Brijs, et al.The Journal of Clinical Endocrinology and Metabolism|September 1, 1987
Relationship of cardiac chamber volume to baroreflex activity in normal humansE G Nabel, W S Colucci, L S Lilly, et al.The New England Journal of Medicine|May 3, 2001
Race and the response to adrenergic blockade with carvedilol in patients with chronic heart failureC W Yancy, M B Fowler, W S Colucci, et al.The American Journal of Psychiatry|June 30, 2000
Is the 5-HT(1Dbeta) receptor gene implicated in the pathogenesis of obsessive-compulsive disorder?E Mundo, M A Richter, F Sam, et al.Accident; Analysis and Prevention|August 11, 2021
Injury-severity analysis of intercity bus crashes in Ghana: A random parameters multinomial logit with heterogeneity in means and variances approachJames Damsere-Derry, Emmanuel Kofi Adanu, Thomas Kolawole Ojo, et al.Accident; Analysis and Prevention|July 3, 2021
Investigating factors affecting bus/minibus accident severity in a developing country for different subgroup datasets characterised by time, pavement, and light conditionsReuben Tamakloe, Sungho Lim, Enoch F Sam, et al.Radiation Protection Dosimetry|November 2, 2022
ANALYSES OF SOME CALL FACTORS AFFECTING SAR LEVELS OF GSM MOBILE PHONES USED IN GHANAS Osei, J K Amoako, F Sam, et al.British Journal of Pharmacology|February 28, 2007
Effects of levosimendan on cardiac remodeling and cardiomyocyte apoptosis in hypertensive Dahl/Rapp ratsM Louhelainen, E Vahtola, P Kaheinen, et al.Journal of the American College of Cardiology|March 1, 1986
Survival of patients with severe congestive heart failure treated with oral milrinoneD S Baim, W S Colucci, E S Monrad, et al.Journal of the American College of Cardiology|October 1, 1993
Efficacy of phosphodiesterase inhibition with milrinone in combination with converting enzyme inhibitors in patients with heart failure. The Milrinone Multicenter Trials InvestigatorsW S Colucci, E H Sonnenblick, K F Adams, et al.Pageof 17